Pharmacotherapy of cerebellar disorders, including CACNAIA
Michael Strupp, MD, FRCP, FAAN, FANA, FEAN, Department of Neurology, Ludwig Maximilians University Hospital in Munich, Germany, and a member of the CACNA1A Foundation's Board of Directors, discusses 4-aminopyridine and acetyl-leucine and other treatments for cerebellar ataxia.
▶︎
Movement Disorders (ataxia, dystonia, eye movements): Ask the Experts Anything Panel
▶︎
CACNA1A 101: The Genetics of CACNA1A
▶︎
The Neurobiology of ADHD
▶︎
An Integrative, Pathology-Centered Perspective on Anal, Oral and Oropharyngeal HPV in Women
▶︎
Dr. Arina Bingeliene - Pediatric Sleep Education Day - Saturday, May 23, 2026
▶︎
If You Have A Bad Memory, I’ll Help You Fix It In 28 Minutes
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
Midbrain Lesions: Benedikt, Weber, Claude, Parinaud Syndrome
▶︎
How Your Brain Works & Changes | Huberman Lab Essentials
▶︎
Ask the Experts Anything Panel about Hemiplegic Migraines and Epilepsy
▶︎
But what is quantum computing? (Grover's Algorithm)
▶︎
Alone During a Heart Attack? 3 Emergency Actions That Can Save Your Life!
▶︎
The Most Misunderstood Concept in Physics
▶︎
Essentials: How to Build Strength, Muscle Size & Endurance | Dr. Andy Galpin
▶︎
Sanocare Breath of Hope with Dr Pieter Ekermans
▶︎
Understanding Your Child’s Neurodevelopmental or Neuropsychological Evaluation
▶︎
COMP Research Discovery (RD) - 2026 May: Emerging Methods in Radiotherapy Dosimetry
▶︎
Medical Historian Answers History of Medicine Questions | Tech Support | WIRED
▶︎
mRNA COVID shots linked to blood clots? McCullough stuns Senate with explosive claims | 2025 REWIND
▶︎